Description: Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.
Home Page: www.cochlear.com
1 University Avenue
Sydney,
NSW
2109
Australia
Phone:
61 2 9428 6555
Officers
| Name | Title |
|---|---|
| Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, Pres & Exec. Director |
| Mr. Stuart Sayers | Chief Financial Officer |
| Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer |
| Mr. Anthony Bishop | Pres of Asia Pacific & Latin America |
| Ms. Lisa Aubert | Pres of North America |
| Mr. Richard Brook MBA | Pres of EMEA |
| Mr. David Hackshall | Chief Information Officer |
| Ms. Kristina Devon | VP of Investor Relations |
| Ms. Jennifer Stevenson | VP of Corp. Communications & Brand |
| Mr. Dean Phizacklea | Sr. VP of Global Strategic Marketing |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 46.0829 |
|---|---|
| Trailing PE: | 48.7279 |
| Price-to-Book MRQ: | 8.1488 |
| Price-to-Sales TTM: | 5.5522 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 4500 |